Osteoarthritis genetics: Current status and future prospects

Future Rheumatology

Volumn 2, Issue 6, 2007, Pages 607-620

  Wilkins, James M ^a   Loughlin, John ^a   Snelling, Sarah J B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ASPN; Association study; FRZB; GDF5; Genetics; Osteoarthritis; TGF ; Wnt

Indexed keywords

ANALGESIC AGENT; ARGININE; ASPORIN; FRIZZLED PROTEIN; GLYCINE; GROWTH DIFFERENTIATION FACTOR 5; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; DEVELOPED COUNTRY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETICS; HAND DISEASE; HIP OSTEOARTHRITIS; HUMAN; JOINT PROSTHESIS; KNEE OSTEOARTHRITIS; MOLECULAR DYNAMICS; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; PALLIATIVE THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 37649022047     PISSN: 17460816     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460816.2.6.607     Document Type: Review

References (100)

1. Reginato AM, Olsen BR: The role of structural genes in the pathogenesis of osteoarthritic disorders. Arthritis. Res. 4, 337-345 (2002).
2. Stecher R: Heberden's nodes: heredity in hypertrophic arthritis of finger joints. Am. J. Med. Sci. 201, 801-809 (1941).
3. Hirsch R, Lethbridge-Cejku M, Hanson R et al.: Familial aggregation of osteoarthritis: data from the Baltimore Longitudinal Study on Aging. Arthritis Rheum. 41, 1227-1232 (1998).
4. Jonsson H, Manolescu I, Stefansson SE et al.: The inheritance of hand osteoarthritis in Iceland. Arthritis Rheum. 48, 391-395 (2003).
5. Chitnavis J, Sinsheimer JS, Clipsham K et al.: Genetic influences in end-stage osteoarthritis. Sibling risks of hip and knee replacement for idiopathic osteoarthritis. J. Bone Joint Surg. Br. 79, 660-664 (1997).
6. Lanyon P, Muir K, Doherty S, Doherty M: Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. Br. Med. J. 321, 1179-1183 (2000).
7. Neame RL, Muir K, Doherty S, Doherty M. Genetic risk of knee osteoarthiritis: a sibling study. Ann. Rheum. Dis. 63, 1022-1027 (2004).
8. Spector TD, MacGregor AJ: Risk factors for osteoarthritis: genetics. Osteoarthr. Cartil. 12(Suppl. A), S39-S44 (2004).
9. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D: Genetic influences on osteoarthritis in women: a twin study. Br. Med. J. 312, 940-943 (1996).
10. MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector TD: The genetic contribution to radiographic hip osteoarthritis in women: results of a classic twin study. Arthritis Rheum. 43, 2410-2416 (2000).
11. Kellgren JH, Lawrence JS, Bier F: Genetic factors in generalized osteoarthrosis. Ann. Rheum. Dis. 22, 237-255 (1963).
12. Loughlin J: Genetic epidemiology of primary osteoarthritis. Curr. Opin. Rheumatol. 13, 111-116 (2001).
13. Tabor HK, Risch NJ, Myers RM: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3, 391-397 (2002).
14. Loughlin J: Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting. Curr. Opin. Rheumatol. 17, 629-633 (2005).
15. Peach CA, Carr AJ, Loughlin J: Recent advances in the genetic investigation of osteoarthritis. Trends Mol. Med. 11, 186-191 (2005).
16. Cheng JC, Tang NL, Yeung HY, Miller N: Genetic association of complex traits: using idiopathic scoliosis as an exarnple. Clin. Orthop. Relat. Res. 462, 38-44 (2007).
17. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T et al: Replicating genotype-phenotype associations. Nature 447, 655-660 (2007).
18. Palmer LJ, Cardon LR: Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366, 1223-1234 (2005).
19. Loughlin J, Dowling B, Chapman K et al.: Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc. Natl Acad. Sci. USA 101, 9757-9762 (2004).
20. Kizawa H, Kou I, Iida A et al.: An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37, 138-144 (2005).
21. Mototani H, Mabuchi A, Saito S et al.: A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthrids in Japanese. Hum. Mol. Genet. 14, 1009-1017 (2005).
22. Miyamoto Y, Mabuchi A, Shi D et al.: A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39, 529-533 (2007).
23. Spector TD, Reneland RH, Mah S et al.: Association between a variation in LRCH1 and knee osteoarthritis: a genome-wide single-nucleotide polymorphism association study using DNA pooling. Arthritis Rheum. 54, 524-532 (2006).
24. Mahr S, Burmester GR, Hilke D et al.: Cis- and trans-acting gene regulation is associated with osteoarthritis. Am. J. Hum. Genet. 78, 793-803 (2006).
25. Glass DA 2nd, Karsenty G: In vivo analysis of Wnt signaling in bone. Endocrinology 148, 2630-2634 (2007).
26. Yates KE, Shortkroff S, Reish RG: Wnt influence on chondrocyte differentiation and cartilage function. DNA Cell Biol. 24, 446-457 (2005).
27. Hoang B, Moos M Jr, Vukicevic S, Luyten FP: Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J. Biol. Chem. 271, 26131-26137 (1996).
28. Snelling S, Ferreira A, Loughlin J: Allelic expression analysis suggests that cis- acting polymorphism of FRZB expression does not contribute to osteoarthritis susceptibility. Osteoarthr. Cartil. 15, 90-92 (2007).
29. Lane NE, Lian K, Nevitt MC et al.: Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 54, 1246-1254 (2006).
30. Min JL, Meulenbelt I, Riyazi N et al.: Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum. 52, 1077-1080 (2005).
31. Rodriguez-Lopez J, Pombo-Suarez M, Liz M, Gomez-Reino JJ, Gonzalez A: Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis. Ann. Rheum. Dis. 66, 1052-1055 (2007).
32. Lories RJ, Boonen S, Peetess J, de Vlam K, Luyten FP: Evidence for a differential association of the Arg200Trp single-nucleotide polymorphism in FRZB with hip osteoarthritis and osteoporosis. Rheumatology 45, 113-114 (2006).
33. Shanmugam KS, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B: The functional genetic variant Arg324Gly of frizzled-related protein (FRZB) is associated with colorectal cancer risk. Carcinogenesis 28, 1914-1917 (2007).
34. Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D: Identification and characterization of asporin. A novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J. Biol. Chem. 276, 12201-12211 (2001).
35. Henry SP, Takanosu M, Boyd TC et al.: Expression pattern and gene characterization of asporin. A newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276, 12212-12221 (2001).
36. Kresse H, Schonherr E: Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189, 266-274 (2001).
37. Ameye L, Young MF: Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12, 107R-116R (2002).
38. Cobrun B: Osteoarthritis? Try asporin. Clin. Genet. 67, 394-395 (2005).
39. Mustafa Z, Dowling B, Chapman K, Sinsheimer JS, Carr A, Loughlin J: Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population. Arthritis Rheum. 52, 3502-3506 (2005).
40. Kaliakatsos M, Tzetis M, Kanavakis E et al.: Asporin and knee osteoarthritis in patients of Greek origin. Osteoarthr. Cartil. 14, 609-611 (2006).
41. Rodriguez-Lopez J, Pombo-Suarez M, Liz M, Gomez-Reino JJ, Gonzalez A: Lack, of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians. Arthritis Res. Ther. 8, R55 (2006).
42. Jiang Q, Shi D, Yi L et al.: Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J. Hum. Genet. 51, 1068-1072 (2006).
43. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat. Genet. 29, 306-309 (2001).
44. Ikegawa S, Kawamura S, Takahashi A, Nakamura T, Kamatani N: Replication of association of the D-repeat polymorphism in asporin with osteorarthritis. Arthritis Res. Ther. 8, 403 (2006).
45. Nakamura T, Shi D, Tzetis M et al.: Meta-analysis of association between the ASPN D-repeat and osteoarthritis. Hum. Mol. Genet. 16, 1676-1678 (2007).
46. Lau J, Ioannidis JP, Schmid CH: Summing up evidence: one answer is not always enough. Lancet 351, 123-127 (1998).
47. Nevitt MC, Xu L, Zhang Y et al.: Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum. 46, 1773-1779 (2002).
48. Lau EM, Lin F, Lam D, Silman A, Croft P: Hip osteoarthritis and dysplasia in Chinese men. Ann. Rheum. Dis. 54, 965-969 (1995).
49. Yoshimura N, Campbell L, Hashimoto T et al.: Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br. J. Rheumatol. 37, 1193-1197 (1998).
50. Hatakeyama Y, Tuan RS, Shum L: Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J. Cell. Biochem. 91, 1204-1217 (2004).
51. Ducy P, Karsenty G: The family of bone morphogenetic proteins. kidney Int. 57, 2207-2214 (2000).
52. Erlacher L, McCartney J, Piek E et al.: Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J. Bone Miner. Res. 13, 383-392 (1998).
53. Hötten GC, Matsumoto T, Kimura M et al.: Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13, 65-74 (1996).
54. Erlacher L, Ng CK, Ullrich R, Krieger S, Luyten FP: Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum. 41, 263-273 (1998).
55. Wolfinan NM, Hattersley G, Cox K et al.: Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J. Clin. Invest. 100, 321-330 (1997).
56. Reddi AH: Bone morphogenetic proteins and skeletal development: the kidney-bone connection. Pediatr. Nephrol. 14, 598-601 (2000).
57. Mikic B: Multiple effects of GDF-5 deficiency on skeletal tissues: implications for therapeutic bioengineering. Ann. Biomed. Eng. 32, 466-476 (2004).
58. Polinkovsky A, Robin NH, Thomas JT et al.: Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat. Genet. 17, 18-19 (1997).
59. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP: A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nat. Genet. 12, 315-317 (1996).
60. Thomas JT, Kilpatrick MW, Lin K et al.: Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet. 17, 58-64 (1997).
61. Holder-Espinasse M, Escande F, Mayrargue E et al.: Angel-shaped phalangeal dysplasia, hip dysplasia, and positional teeth abnormalities are part of the brachydactyly C spectrum associated with CDMP-1 mutations. J. Med. Genet. 41, e78 (2004).
62. Warashina H, Sakano S, Kitamura S, Yamauchi K, Kito H, Hasegawa Y: Total hip arthroplasty for a patient with angel-shaped phalango-epiphyseal dysplasia (ASPED). A case report. Nagoya J. Med. Sci. 65, 103-107 (2002).
63. Southam L, Rodriguez-Lopez J, Wilkins JM et al.: A SNP in the 5′ UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet. 16, 2226-2232 (2007).
64. Yamada S, Tomoeda M, Ozawa Y et al.: PLAP-1/asporin: A novel negative regulator of periodontal ligament mineralization. J. Biol. Chem. 282, 23070-23080 (2007).
65. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F: p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell Res. 250, 351-363 (1999).
66. Sieber C, Ploger F, Schwappacher R et al.: Monomeric and dimeric GDF5 show equal type I receptor binding and oligomerization capability and have the same biological activity. Biol. Chem. 387, 451-460 (2006).
67. Wawrzak D, Metioui M, Willems E, Hendrickx M, de Genst E, Leyns L: Wnt3a binds to several sFRPs in the nanomolar range. Biochem. Biophys. Res. Commun. 357, 1119-1123 (2007).
68. Qian D, Jones C, Rzadzinska A et al.: Wnt5a fuctions in planar cell polarity regulation in mice. Dev. Biol. 306, 121-133 (2007).
69. Person AD, Garriock RJ, Krieg PA, Runyan RB, Klewer SE: Frzb modulates Wnt-9a-mediated β-catenin signaling during avian atrioventricular cardiac cushion development. Dev. Biol. 278, 35-48 (2005).
70. Zhou S, Eid K, Glowacki J: Cooperation between TGF-β and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J. Bone Miner. Res. 19, 463-470 (2004).
71. Chen Y, Whetstone HC, Youn A et al.: β-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Mol. Chem. 282, 526-533 (2007).
72. Guo X, Day TF, Jiang X, Garrett-Beal L, Topol L, Yang Y: Wnt/ β-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 18, 2404-2417 (2004).
73. Reinhold MI, Kapadia RM, Liao Z, Naski MC: The Wnt-inducible transcription factor Twistl inhibits chondrogenesis. J. Biol. Chem. 281, 1381-1388 (2006).
74. Kawakami Y, Wada N, Nishimatsu SI, Ishikawa T, Noji S, Nohno T: Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud. Dev. Growth Differ. 41, 29-40 (1999).
75. Spater D, Hill TP, O'Sullivan RJ, Gruber M, Conner DA, Hartmann C: Wnt9a signaling is required for joint integrity aad regulation of Ihh during chondrogenesis. Development 133, 3039-3049 (2006).
76. Shintani N, Hunziker EB: Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transfarming growth factor β1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum. 56, 1869-1879 (2007).
77. Han F, Adams CS, Tao Z et al.: Tramforming growth factor-β1 (TGF-β1) regulates ATDC5 chondrogenic differenriation and fibronectin isoform expression. J. Cell. Biochem. 95, 750-762 (2005).
78. Chimal-Monroy J, Diaz de Leon L: Differential effects of transforming growth factors β 1, β 2, β 3 and β 5 on chondrogenesis in mouse limb bud mesenchymal cells. Int. J. Dev. Biol. 41, 91-102 (1997).
79. Pagnotto MR, Wang Z, Karpie JC, Ferretti M, Xiao Y, Chu CR: Adeno-associated viral gene transfer of transforming growth factor-βl to human mesenchymal stem cells improves cartilage repair. Gene Ther. 14, 804-813 (2007).
80. Robbins JR, Evanko SP, Vogel KG: Mechanical loading and TGF-β regulate proteoglycan synthesis in tendon. Arch. Biochem. Bioplys. 342, 203-211 (1997).
81. Spindler KP, Imro AK, Mayes CE, Davidson JM: Patellar tendon and anterior cruciate ligament have different mitogenic responses to platelet-derived growth factor and transforming growth factor β. J. Orthop. Res. 14, 542-546 (1996).
82. Selvamurugan N, Kwok S, Alliston T, Reiss M, Partridge NC: Transforming growth Factor-β 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx:2. J. Mol. Chem. 279, 19327-19334 (2004).
83. Coleman CM, Tuan RS: Growth/differentiation factor 5 enhances chondrocyte maturation. Dev. Dyn. 228, 208-216 (2003).
84. Francis-West PH, Abdelfattah A, Chen P et al.: Mechanisms of GDF5 action during skeletal development. Development 126, 1305-1315 (1999).
85. Rickert M, Wang H, Wieloch P et al.: Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes; and the healing rat Achilles tendon. Connect. Tissue Res. 46, 175-183 (2005).
86. Nakamura T, Yamamoto M, Tamura M, Izumi Y. Effects of growth/ differentiation factor-5 on human periodontal ligament cells. J. Periodontal Res. 38, 597-605 (2003).
87. Chhabra A, Tsou D, Clark RT, Gaschen V, Hunziker EB, Mikic B: GDF5 deficiency in mice delays Achilles tendon healing. J. Orthop Res. 21, 826-835 (2003).
88. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F: p38 mitogen-activated protein kinase funtionally contributes to chondrogenesis induced by growth/differendation factor-5 in ATDC5 cells. Exp. Cell Res. 250, 351-363 (1999).
89. Sammar M, Stricker S, Schwabe GC et al.: Modulation of GDF5/BR1-P signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 9, 1227-1238 (2004).
90. Jin EJ, Lee SY. Choi YA, Jung JC, Bang OS, Kang SS: BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol. Cells 22, 353-359 (2006).
91. Chen Y, Whetstone HC, Youn A et al.: β-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 282, 526-533 (2007).
92. International Human Genome Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature 431, 931-945 (2004).
93. Sachidanandam R, Weissman D, Schmidt SC et al.: A map of human genome sequence variation containing 1.42 million single nucleodde polymorphisms. Nature 409, 928-933 (2001).
94. Cardon LR, Watkins H: Waiting for the working draft from the human genome project. A huge achievement, but not of immediate medical use. Br. Med. J. 320, 1223-1224 (2000).
95. The International HapMap Consortium: The International HapMap Project. Nature 426, 789-796 (2003).
96. Barrett JC, Cardon LR: Evaluating coverage of genome-wide association studies. Nat. Genet. 38, 659-662 (2006).
97. Peer I, de Bakker PI, Maller J, Yelensky R, Altshuler D, Daly MJ: Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat. Genet. 38, 663-667 (2006).
98. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
99. ENCODE Project Consortium: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007).
100. Knight JC: Regulatory polymorphisms underlying complex disease traits. J. Mol. Med. 83, 97-109 (2005).